|
|
Post by hawaiiguy42 on Jan 1, 2016 10:08:36 GMT -5
Jim Dixon was hired on or about July/August 2015... that was 4 or 5 months ago. Developing a solid POAs (Plan of Actions) take a least 3 months to which would bring us to about November or December 2015. Then taking into consideration of training sales staff, another 30 to 60 days, brings us to January to February 2016. Point being the big push for marketing Afrezza has not begun, hence the probability as to why sales are flat-lined. Current sales past to present are more likely do to word of mouth, few news cast, and postings on websites. It is my belief, Afrezza should begin seeing a dramatic rise is Afrezza users beginning May of 2016. This is my MDMP process coming into play (thought analysis and projections).
Jim appears to of had a stellar career and J&J... do some DD.
Director, Patient Marketing - AFREZZA® at Sanofi
location
Greater New York City Area
industry
Marketing and Advertising
Current Director, Patient Marketing - AFREZZA® at Sanofi
Past Sr. Marketing Manager, Worldwide Transfusion Medicine at Johnson & Johnson, Ortho Clinical Diagnostics, Brand Manager, MONISTAT® Brand...
Education Rutgers University-New Brunswick, Penn State University
Summary Dynamic, forward-thinking Marketing Professional with 15+ years of demonstrated business success, continuous development progression, and...
Summary
Dynamic, forward-thinking Marketing Professional with 15+ years of demonstrated business success, continuous development progression, and demonstrated learning agility across diverse experiences within Multi-million dollar Consumer Packaged Goods and Medical Device & Diagnostics businesses and brands.
A classically trained marketer and global strategist at Johnson & Johnson who leverages a unique combination of marketing skills and a dynamic & collaborative leadership style to deliver strong business results. Builds brands and drives value in strategic business planning, product development, & targeted communications through true customer-centric insights across multiple brands and healthcare sectors at Johnson & Johnson.
A passionate leader with extensive experience managing a wide variety of direct reports, as well as effectively influencing cross-functional partners to deliver strong business results. Committed to recruiting top talent and developing people for the benefits of the business and their own career development.
Specialties: Global & US Marketing, Global & US Strategy, Branding and Equity building, Media & Communications Development, New Product Pipeline Development, New Product Launches, P&L management, Strategic Planning.
|
|
|
|
Post by nadathing on Jan 1, 2016 10:45:42 GMT -5
Thanks for a great post to start off the New Year!
|
|
|
|
Post by grandpoobah on Jan 1, 2016 12:23:20 GMT -5
Jim Dixon was hired on or about July/August 2015... that was 4 or 5 months ago. Developing a solid POAs (Plan of Actions) take a least 3 months to which would bring us to about November or December 2015. Then taking into consideration of training sales staff, another 30 to 60 days, brings us to January to February 2016. Point being the big push for marketing Afrezza has not begun, hence the probability as to why sales are flat-lined. Current sales past to present are more likely do to word of mouth, few news cast, and postings on websites. It is my belief, Afrezza should begin seeing a dramatic rise is Afrezza users beginning May of 2016. This is my MDMP process coming into play (thought analysis and projections). Jim appears to of had a stellar career and J&J... do some DD. Director, Patient Marketing - AFREZZA® at Sanofi location Greater New York City Area industry Marketing and Advertising Current Director, Patient Marketing - AFREZZA® at Sanofi Past Sr. Marketing Manager, Worldwide Transfusion Medicine at Johnson & Johnson, Ortho Clinical Diagnostics, Brand Manager, MONISTAT® Brand... Education Rutgers University-New Brunswick, Penn State University Summary Dynamic, forward-thinking Marketing Professional with 15+ years of demonstrated business success, continuous development progression, and... Summary Dynamic, forward-thinking Marketing Professional with 15+ years of demonstrated business success, continuous development progression, and demonstrated learning agility across diverse experiences within Multi-million dollar Consumer Packaged Goods and Medical Device & Diagnostics businesses and brands. A classically trained marketer and global strategist at Johnson & Johnson who leverages a unique combination of marketing skills and a dynamic & collaborative leadership style to deliver strong business results. Builds brands and drives value in strategic business planning, product development, & targeted communications through true customer-centric insights across multiple brands and healthcare sectors at Johnson & Johnson. A passionate leader with extensive experience managing a wide variety of direct reports, as well as effectively influencing cross-functional partners to deliver strong business results. Committed to recruiting top talent and developing people for the benefits of the business and their own career development. Specialties: Global & US Marketing, Global & US Strategy, Branding and Equity building, Media & Communications Development, New Product Pipeline Development, New Product Launches, P&L management, Strategic Planning. According to linkedin: linkedin profileHis tenure as "Director, Patient Marketing - AFREZZA" with Sanofi has been "January 2015 – Present (1 year 1 month)." And tampons, pantyliners, vaginal creams, and Bengay? Was it all that difficult to find someone more familiar with diabetes and diabetics? |
|
|
|
Post by madman63 on Jan 1, 2016 12:36:11 GMT -5
Click his LinkedIn profile and then view other connections associated with SNY and/or Afrezza. All from a year or more ago. I question what they have actually been doing for the past year.
|
|
|
|
Post by barnstormer on Jan 1, 2016 12:42:17 GMT -5
Sometimes the best executives are the ones that come in with fresh eyes and no baggage. He has a great pedigree and good education. He will do just fine.
|
|
|
|
Post by grandpoobah on Jan 2, 2016 9:35:56 GMT -5
An interesting article discussing things often overlooked in drug launches: The seven worst mistakes of pharma launch (and secrets to avoid themWhile I saw several on the list that likely would apply to afrezza's launch effort, I though number "1" stood out: "1. Focusing on Product, Forgetting Everything Else Sure, a big part of launching a drug revolves around the drug itself - developing the chemical composition, submitting the drug for approval, ensuring formulary positioning, and more all focus on the physical product. But often lost in the mix is the customer and market. Long before a product is complete and ready for sale, you need a deep understanding of your customers and the market youre targeting. That means understanding, in-depth, some key points: The disease you're treating, including standards of care for that therapeutic area The people it affects The needs of patients with the disease The needs of physicians treating these patients Key opinion leaders and professional associations in the therapeutic area Trends in patient access, managed care acceptance and reimbursement in the disease area Key regulatory milestones and requirements affecting the disease and the product To further know your market, you must also understand your product in terms of the competition that already exists, and that which is likely to develop before and after launch. Knowing how your product will stack up against other players in the marketplace points toward the true benefits of your drug for customers. Pre-launch planning should include some tough questions: How is your product better than the pharmaceuticals and intervention that already exist? How can an average customer, payer, physician or pharmacist differentiate between your product and its competition? How will the product provide benefit that is different than other pharmas offerings? How will your competitors respond to your market entry? How will the competitive landscape change over time? Is this area going to explode with entries? Will generics infiltrate soon?" |
|
|
|
Post by hawaiiguy42 on Jan 2, 2016 18:00:05 GMT -5
Jim Dixon was hired on or about July/August 2015... that was 4 or 5 months ago. Developing a solid POAs (Plan of Actions) take a least 3 months to which would bring us to about November or December 2015. Then taking into consideration of training sales staff, another 30 to 60 days, brings us to January to February 2016. Point being the big push for marketing Afrezza has not begun, hence the probability as to why sales are flat-lined. Current sales past to present are more likely do to word of mouth, few news cast, and postings on websites. It is my belief, Afrezza should begin seeing a dramatic rise is Afrezza users beginning May of 2016. This is my MDMP process coming into play (thought analysis and projections). Jim appears to of had a stellar career and J&J... do some DD. Director, Patient Marketing - AFREZZA® at Sanofi location Greater New York City Area industry Marketing and Advertising Current Director, Patient Marketing - AFREZZA® at Sanofi Past Sr. Marketing Manager, Worldwide Transfusion Medicine at Johnson & Johnson, Ortho Clinical Diagnostics, Brand Manager, MONISTAT® Brand... Education Rutgers University-New Brunswick, Penn State University Summary Dynamic, forward-thinking Marketing Professional with 15+ years of demonstrated business success, continuous development progression, and... Summary Dynamic, forward-thinking Marketing Professional with 15+ years of demonstrated business success, continuous development progression, and demonstrated learning agility across diverse experiences within Multi-million dollar Consumer Packaged Goods and Medical Device & Diagnostics businesses and brands. A classically trained marketer and global strategist at Johnson & Johnson who leverages a unique combination of marketing skills and a dynamic & collaborative leadership style to deliver strong business results. Builds brands and drives value in strategic business planning, product development, & targeted communications through true customer-centric insights across multiple brands and healthcare sectors at Johnson & Johnson. A passionate leader with extensive experience managing a wide variety of direct reports, as well as effectively influencing cross-functional partners to deliver strong business results. Committed to recruiting top talent and developing people for the benefits of the business and their own career development. Specialties: Global & US Marketing, Global & US Strategy, Branding and Equity building, Media & Communications Development, New Product Pipeline Development, New Product Launches, P&L management, Strategic Planning.
linkedin profile
His tenure as "Director, Patient Marketing - AFREZZA" with Sanofi has been "January 2015 – Present (1 year 1 month)."
And tampons, pantyliners, vaginal creams, and Bengay? Was it all that difficult to find someone more familiar with diabetes and diabetics? Apparently he's doing something right, scripts are increasing and more HMOs are now listing Afrezza. So.... it's not all about tampons, pantyliners, vaginal creams, and Begay... it's about how you get the product out there... specifically distribution/sales, etc. |
|
